• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Diffusion-weighted MRI sensitive for metastasis in pelvic lymph nodes

byXiaofan PanandAaron Maxwell, MD
June 11, 2014
in Chronic Disease, Imaging and Intervention, Oncology
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1.Diffusion-weighted magnetic resonance imaging (DWMRI)  was shown to be both sensitive and specific for identification of pelvic lymph node metastases among patients with prostate or bladder cancer. 

2. The inclusion of several additional imaging criteria in conjunction with DWMRI reduced the number of diagnostic errors and was associated with superior sensitivity relative to DWMRI alone. 

Evidence Rating Level: 2 (Good) 

Study Rundown: The presence of metastasis to local lymph nodes alters cancer staging and may influence treatment decisions. The current protocol for the evaluation of lymph node metastasis involves preoperative imaging with either computed tomography (CT) or magnetic resonance imaging (MRI), which detect lymph nodes primarily based on size. These techniques are currently limited by their insensitivity to smaller lymph nodes containing metastases, and may yield falsely positive results in hypertrophic lymph nodes. DWMRI represents a promising alternative detection method, as it is very sensitive to the subtle changes caused by invasion from cancer cells.

In the present study, the performance of DWMRI in the identification of lymph node metastasis was evaluated among patients with prostate or bladder cancer. Using histopathologic evaluation as the reference standard, DWMRI showed a high sensitivity and specificity. The study’s primary limitation was its single-institution design, and further work is necessary to replicate these findings at other medical centers.

Click to read the study in Radiology

RELATED REPORTS

AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality

Cretostimogene reduced recurrence risk in intermediate-risk and high-grade Ta non-muscle invasive bladder cancer in topline phase 3 results

Relevant Reading: Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

In-Depth [nonrandomized clinical trial]: The study enrolled 120 consecutive patients at a single institution with bladder or prostate cancer who had been previously staged as having no metastases (N0) by conventional preoperative cross-sectional imaging (CT and/or MRI). All enrolled patients underwent DWMRI at 3.0 Tesla to evaluate for previously-unidentified pelvic lymph node metastases. Images were reviewed both pre- and postoperatively, as well as in conjunction with standard MRI for the evaluation of several prespecified imaging criteria (e.g. lymph node shape). All patients subsequently underwent tumor resection with extended pelvic lymph node dissection. Imaging results were compared to histopathologic examination of removed lymph nodes for the diagnosis of metastasis. In total, 33 patients (27.5%) had histologically-confirmed metastasis in 88 lymph nodes. Using DWMRI,  metastasis was correctly identified in 24/33 patients, yielding an overall sensitivity, specificity, and diagnostic accuracy of 72.7%, 86.2%, and 82.5%, respectively. Most false negative examinations were in very small nodes, less than 5 millimeters in diameter. Following incorporation of the additional MRI-based imaging criteria into lymph node assessment, sensitivity increased to 94.5%.

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: bladder cancermetastasismriprostate cancer
Previous Post

Addition of insulin to metformin in Type 2 Diabetes may increase risk of mortality

Next Post

Hydrolyzed formula in susceptible infants does not reduce Diabetes-linked autoantibodies

RelatedReports

Physical activity collage: an engraved bicycle, a water bottle lying on its side and a path of flat stepping stones
Artificial Intelligence

AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality

November 19, 2026
Bladder health collage: an anatomical drawing of the bladder with its ureters and urethra beside a water droplet
2MM Trial Briefs

Cretostimogene reduced recurrence risk in intermediate-risk and high-grade Ta non-muscle invasive bladder cancer in topline phase 3 results

November 18, 2026
A cross-section of the bladder showing cancer cells and immune cells interacting, suggesting immunotherapy for bladder cancer.
2MM Trial Briefs

Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer

November 14, 2026
Collage on the PSA blood test: an engraved bladder and prostate, a capped blood tube, a balance scale and a blank calendar
2MM Trial Briefs

American Cancer Society recommends regular PSA-based screening for men at average and higher risk

November 12, 2026
Next Post

Hydrolyzed formula in susceptible infants does not reduce Diabetes-linked autoantibodies

Levodopa for Parkinson’s disease more effective than newer generation therapies

Levodopa for Parkinson’s disease more effective than newer generation therapies

Combination CPAP, weight loss for obstructive sleep apnea offer no added benefit

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Interim global phase 2 AZUR-1 results show durable responses with dostarlimab monotherapy in untreated MSI-H/dMMR stage II/III locally advanced rectal cancer
  • AI health chatbot shows no benefit for perinatal anxiety or depression
  • ADCE-D01 showed a 30% objective response rate in topline phase 1 results for previously treated advanced soft tissue sarcoma
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.